Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed on its ...
2h
Pfizer (NYSE:PFE) is currently dealing with shareholder proposals concerning governance issues such as religious ...
Novo Nordisk announced disappointing data from a phase III study on a novel obesity candidate, CagriSema. Roche announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback